Xiaflex: Phase IIb started

By WIR Staff | Feb 22, 2016 | 8:00 AM GMT

Endo began a placebo-controlled, U.S. Phase IIb trial to evaluate 0.84 mg collagenase clostridium histolyticum per session

Read the full 174 word article

How to gain access

Continue reading with a
two-week free trial.